Objective The risk-benefit profile of antidepressant medications in bipolar disorder is
controversial. When conclusive evidence is lacking, expert consensus can guide treatment …

This paper, which has been reviewed and approved by the Board of Directors of the
American Sleep Disorders Association, provides the background for the Standards of …

Background Despite the longer duration of the depressive phase in bipolar disorder and the
frequent clinical use of antidepressants combined with antipsychotics or mood stabilizers …

Bipolar disorder (BD) is a highly debilitating psychiatric illness that may affect as many as 1
in every 25 persons. This chapter discusses current research findings in BD. BD has been …

Objective This study examined the risk of antidepressant-induced manic switch in patients
with bipolar disorder treated either with antidepressant monotherapy or with an …

Based on the author's work and that of collaborators, as well as other contemporaneous
research, this article reaffirms the existence of a broad bipolar spectrum between the …

The diagnosis and treatment of bipolar disorder (BD) has been in con sis tent and frequently
mis under stood in re cent years. To identify the causes of this problem and suggest possible …

Objective: To assess the co-occurrence of fibromyalgia with psychiatric disorders in
participants of a fibromyalgia family study. Method: Patients (probands) with fibromyalgia …

OBJECTIVE: This study reviewed the evidence from randomized, controlled trials on the
efficacy and safety of antidepressants in the short-term treatment of bipolar depression …

Objective: The role of antidepressants in the acute treatment of bipolar depression remains a
contentious issue. A previous meta-analysis of randomized controlled trials (RCTs) …